Contrasting InterCure (NASDAQ:INCR) and GlucoTrack (NASDAQ:GCTK)

InterCure (NASDAQ:INCR) and GlucoTrack (NASDAQ:GCTK) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

Valuation & Earnings

This table compares InterCure and GlucoTrack”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InterCure	$64.55 million	N/A	-$18.32 million	$0.03	25.00
GlucoTrack	N/A	N/A	-$19.39 million	($55.51)	-0.01

InterCure has higher revenue and earnings than GlucoTrack. GlucoTrack is trading at a lower price-to-earnings ratio than InterCure, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and recommmendations for InterCure and GlucoTrack, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InterCure	1	0	0	0	1.00
GlucoTrack	1	0	0	0	1.00

Insider & Institutional Ownership

8.3% of InterCure shares are owned by institutional investors. Comparatively, 10.9% of GlucoTrack shares are owned by institutional investors. 2.2% of GlucoTrack shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Risk and Volatility

InterCure has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, GlucoTrack has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500.

Profitability

This table compares InterCure and GlucoTrack’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InterCure	N/A	N/A	N/A
GlucoTrack	N/A	-324.84%	-178.16%

Summary

InterCure beats GlucoTrack on 7 of the 9 factors compared between the two stocks.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

About GlucoTrack

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.